Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD7624 in frequent-exacerbation COPD on maintenance therapy
2014-001053-16Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD7624 in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jul 2014; status: completed.
02
Drugs
AZD7624
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2014-001053-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001053-16.